1-5 of 5
chile
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cure at what (systemic) financial cost? Integrating novel therapies into first-line Hodgkin lymphoma treatment

Scott F. Huntington
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 252–259.
https://doi.org/10.1182/hematology.2019000030
Published: 2019
Journal Articles

Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma

W. Robert Liu, Margaret A. Shipp
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 310–316.
https://doi.org/10.1182/asheducation-2017.1.310
Published: 2017
Journal Articles

Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?

Michelle Fanale
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 406–413.
https://doi.org/10.1182/asheducation-2013.1.406
Published: 2013
Journal Articles

The Present: Optimizing Therapy—Too Much or Too Little?

Nancy L. Bartlett
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 108–114.
https://doi.org/10.1182/asheducation-2010.1.108
Published: 2010
Journal Articles

Biology, Clinical Course and Management of Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Lucia Nogová, Thomas Rudiger, Andreas Engert
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 266–272.
https://doi.org/10.1182/asheducation-2006.1.266
Published: 2006